Delayed treatment effects on time-to-event outcomes are commonly observed in randomized controlled trials of cancer immunotherapies. When the treatment effect has a delayed onset, the conventional test/estimation approach-using the log-rank test for between-gr... ...

请注册登录后继续浏览